Ursa Fund Management’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Ursa Fund Management’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,804,246	Closed	-$7.4M	–	37
2022 Q3	$7.4M	Buy	+2,804,246	New	+$4.13M	5%	4

Other funds holding CANO.WS

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Ursa Fund Management's CANO.WS Position: Q4 2022 in Review

Ursa Fund Management sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2022, closing a stake of 2,804,246 shares — an estimated $7.4M sold.

Ursa Fund Management first reported a position in CANO.WS in Q3 2022 and held it in 1 quarter. The position peaked at $7.4M in Q3 2022. 27 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2022.

Ursa Fund Management reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2022 after selling out during the quarter.
Ursa Fund Management sold 2,804,246 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2022, an estimated $7.4M.
Ursa Fund Management first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q3 2022 and held it in 1 quarter.
Ursa Fund Management's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $7.4M in Q3 2022.
27 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2022.

Based on Ursa Fund Management's 13F filing for Q4 2022, filed 26 Jan 2023.